These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant. Zeitlin L; Pettitt J; Scully C; Bohorova N; Kim D; Pauly M; Hiatt A; Ngo L; Steinkellner H; Whaley KJ; Olinger GG Proc Natl Acad Sci U S A; 2011 Dec; 108(51):20690-4. PubMed ID: 22143789 [TBL] [Abstract][Full Text] [Related]
5. Production of complex multiantennary N-glycans in Nicotiana benthamiana plants. Nagels B; Van Damme EJ; Pabst M; Callewaert N; Weterings K Plant Physiol; 2011 Mar; 155(3):1103-12. PubMed ID: 21233332 [TBL] [Abstract][Full Text] [Related]
6. Expression of a Large Single-Chain 13F6 Antibody with Binding Activity against Ebola Virus-Like Particles in a Plant System. Lim S; Kim DS; Ko K Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977599 [TBL] [Abstract][Full Text] [Related]
7. Differential N-glycosylation of a monoclonal antibody expressed in tobacco leaves with and without endoplasmic reticulum retention signal apparently induces similar in vivo stability in mice. Triguero A; Cabrera G; Rodríguez M; Soto J; Zamora Y; Pérez M; Wormald MR; Cremata JA Plant Biotechnol J; 2011 Dec; 9(9):1120-30. PubMed ID: 21819534 [TBL] [Abstract][Full Text] [Related]
8. Trastuzumab and Pertuzumab Plant Biosimilars: Modification of Asn297-linked Glycan of the mAbs Produced in a Plant with Fucosyltransferase and Xylosyltransferase Gene Knockouts. Komarova TV; Sheshukova EV; Kosobokova EN; Serebryakova MV; Kosorukov VS; Tashlitsky VN; Dorokhov YL Biochemistry (Mosc); 2017 Apr; 82(4):510-520. PubMed ID: 28371609 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo efficacy of anti-chikungunya virus monoclonal antibodies produced in wild-type and glycoengineered Nicotiana benthamiana plants. Hurtado J; Acharya D; Lai H; Sun H; Kallolimath S; Steinkellner H; Bai F; Chen Q Plant Biotechnol J; 2020 Jan; 18(1):266-273. PubMed ID: 31207008 [TBL] [Abstract][Full Text] [Related]
10. Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Strasser R; Stadlmann J; Schähs M; Stiegler G; Quendler H; Mach L; Glössl J; Weterings K; Pabst M; Steinkellner H Plant Biotechnol J; 2008 May; 6(4):392-402. PubMed ID: 18346095 [TBL] [Abstract][Full Text] [Related]
11. N-glycosylation engineering of plants for the biosynthesis of glycoproteins with bisected and branched complex N-glycans. Castilho A; Gattinger P; Grass J; Jez J; Pabst M; Altmann F; Gorfer M; Strasser R; Steinkellner H Glycobiology; 2011 Jun; 21(6):813-23. PubMed ID: 21317243 [TBL] [Abstract][Full Text] [Related]
12. Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies. Aoyama M; Hashii N; Tsukimura W; Osumi K; Harazono A; Tada M; Kiyoshi M; Matsuda A; Ishii-Watabe A MAbs; 2019 Jul; 11(5):826-836. PubMed ID: 30990348 [TBL] [Abstract][Full Text] [Related]
13. Processing of complex N-glycans in IgG Fc-region is affected by core fucosylation. Castilho A; Gruber C; Thader A; Oostenbrink C; Pechlaner M; Steinkellner H; Altmann F MAbs; 2015; 7(5):863-70. PubMed ID: 26067753 [TBL] [Abstract][Full Text] [Related]
14. Production of a tumour-targeting antibody with a human-compatible glycosylation profile in N. benthamiana hairy root cultures. Lonoce C; Salem R; Marusic C; Jutras PV; Scaloni A; Salzano AM; Lucretti S; Steinkellner H; Benvenuto E; Donini M Biotechnol J; 2016 Sep; 11(9):1209-20. PubMed ID: 27313150 [TBL] [Abstract][Full Text] [Related]
15. Production of different glycosylation variants of the tumour-targeting mAb H10 in Nicotiana benthamiana: influence on expression yield and antibody degradation. Lombardi R; Donini M; Villani ME; Brunetti P; Fujiyama K; Kajiura H; Paul M; Ma JK; Benvenuto E Transgenic Res; 2012 Oct; 21(5):1005-21. PubMed ID: 22238065 [TBL] [Abstract][Full Text] [Related]
16. Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms. Wada R; Matsui M; Kawasaki N MAbs; 2019; 11(2):350-372. PubMed ID: 30466347 [TBL] [Abstract][Full Text] [Related]
17. Glycoform-resolved pharmacokinetic studies in a rat model employing glycoengineered variants of a therapeutic monoclonal antibody. Falck D; Thomann M; Lechmann M; Koeleman CAM; Malik S; Jany C; Wuhrer M; Reusch D MAbs; 2021; 13(1):1865596. PubMed ID: 33382957 [TBL] [Abstract][Full Text] [Related]